Quince Therapeutics logo

Quince Therapeutics Share Price Today

(NASDAQ: QNCX)

Quince Therapeutics share price is $1.54 & ₹133.93 as on 6 Mar 2025, 2.30 'hrs' IST

$1.54

0.07

(4.76%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Quince Therapeutics share price in Dollar and Rupees. Guide to invest in Quince Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Quince Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Quince Therapeutics share price movements

  • Today's Low: $1.46
    Today's High: $1.56

    Day's Volatility :6.41%

  • 52 Weeks Low: $0.51
    52 Weeks High: $2.45

    52 Weeks Volatility :79.12%

Quince Therapeutics (QNCX) Returns

PeriodQuince Therapeutics IncIndex (Russel 2000)
3 Months
-15.38%
0.0%
6 Months
121.17%
0.0%
1 Year
31.62%
0.0%
3 Years
-63.76%
-11.6%

Quince Therapeutics (QNCX) Key Statistics

in dollars & INR

Previous Close
$1.47
Open
$1.44
Today's High
$1.56
Today's Low
$1.46
Market Capitalization
$71.8M
Today's Volume
$48.6K
52 Week High
$2.45
52 Week Low
$0.5116
Revenue TTM
$0.0
EBITDA
$-29.1M
Earnings Per Share (EPS)
$-1.26
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-79.38%

How to invest in Quince Therapeutics Stock (QNCX) from India?

It is very easy for Indian residents to invest directly in Quince Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Quince Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Quince Therapeutics or QNCX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Quince Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Quince Therapeutics shares which would translate to 0.565 fractional shares of Quince Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Quince Therapeutics, in just a few clicks!

Returns in Quince Therapeutics (QNCX) for Indian investors in Rupees

The Quince Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Quince Therapeutics investment value today

Current value as on today

₹1,36,573

Returns

₹36,573

(+36.57%)

Returns from Quince Therapeutics Stock

₹31,624 (+31.62%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Quince Therapeutics (QNCX)

-38%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Quince Therapeutics Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Quince Therapeutics

  • Vanguard Group Inc

    2.89%

  • EPIQ Capital Group, LLC

    1.87%

  • Renaissance Technologies Corp

    1.19%

  • BlackRock Inc

    1.02%

  • Geode Capital Management, LLC

    0.85%

  • HighTower Advisors, LLC

    0.78%

Analyst Recommendation on Quince Therapeutics

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Quince Therapeutics(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Quince Therapeutics Stock (QNCX)

What analysts predicted

Upside of 679.22%

Target:

$12.00

Current:

$1.54

Insights on Quince Therapeutics Stock (Ticker Symbol: QNCX)

  • Price Movement

    In the last 7 days, QNCX stock has moved up by 10.8%
  • QNCX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 34.9%
  • QNCX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 116.4%

Quince Therapeutics Technicals Summary

Sell

Neutral

Buy

Quince Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Quince Therapeutics (QNCX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Quince Therapeutics Inc logo
-0.65%
121.17%
31.62%
-63.76%
-95.96%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Quince Therapeutics Inc logo
NA
NA
NA
-1.14
-0.79
-0.16
NA
1.09
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Quince Therapeutics Inc logo
Sell
$71.8M
-95.96%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Quince Therapeutics

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising EryKit, Syringe Kit, drugs, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Organization
Quince Therapeutics
Employees
32
CEO
Dr. Dirk Thye M.D.
Industry
Healthcare

Management People of Quince Therapeutics

NameTitle
Dr. Dirk Thye M.D.
CEO, Chief Medical Officer & Director
Dr. Charles S. Ryan J.D., Ph.D.
President
Mr. Brendan Hannah M.B.A.
Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer
Mr. Giovanni Mambrini M.Sc.
Chief Technology Officer
Dr. Guenter R. Janhofer M.D., Ph.D.
Chief Scientific Officer
Ms. Stacy Roughan
Vice President of Corporate Communications & Investor Relations
Ms. Mary Ellen Sillivos
Vice President of Human Resources
Dr. Stewart A. Low Ph.D.
Head of Discovery
Ms. Pamela M. Williamson FRAPS, M.B.A., RAC
Head of Regulatory Affairs

Important FAQs about investing in QNCX Stock from India :

What is Quince Therapeutics share price today?

Quince Therapeutics share price today stands at $1.54, Open: $1.44 ; Previous Close: $1.47 ; High: $1.56 ; Low: $1.46 ; 52 Week High: $2.45 ; 52 Week Low: $0.51.

The stock opens at $1.44, after a previous close of $1.47. The stock reached a daily high of $1.56 and a low of $1.46, with a 52-week high of $2.45 and a 52-week low of $0.51.

Can Indians buy Quince Therapeutics shares?

Yes, Indians can invest in the Quince Therapeutics (QNCX) from India.

With INDmoney, you can buy Quince Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Quince Therapeutics at zero transaction cost.

How can I buy Quince Therapeutics shares from India?

It is very easy to buy Quince Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quince Therapeutics (QNCX) be purchased?

Yes, you can buy fractional shares of Quince Therapeutics with INDmoney app.

What are the documents required to start investing in Quince Therapeutics stocks?

To start investing in Quince Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Quince Therapeutics Stock (QNCX)?

Today’s highest price of Quince Therapeutics (QNCX) is $1.56.

Today’s lowest price of Quince Therapeutics (QNCX) is $1.46.

What is today's market capitalisation of Quince Therapeutics?

Today's market capitalisation of Quince Therapeutics QNCX is 71.8M

What is the 52 Week High and Low Range of Quince Therapeutics Stock (QNCX)?

  • 52 Week High

    $2.45

  • 52 Week Low

    $0.51

What are the historical returns of Quince Therapeutics (QNCX)?

  • 1 Month Returns

    -0.65%

  • 3 Months Returns

    121.17%

  • 1 Year Returns

    31.62%

  • 5 Years Returns

    -95.96%

Who is the Chief Executive Officer (CEO) of Quince Therapeutics ?

Dr. Dirk Thye M.D. is the current Chief Executive Officer (CEO) of Quince Therapeutics.